Advertisement
Screener

UNICYCIVE THERAPEUTICS, INC. (UNCY) Beta

UNICYCIVE THERAPEUTICS, INC. (UNCY) Beta

  • Beta · 5-year monthly: Value 1.78; Formula and calculation Saved five-year monthly beta; measures historical sensitivity to the benchmark..

Beta

Overview →

Financial period ending 2026-08-31; current quote 2026-08-31. Amounts retain their stated periods and units.

MetricValueFormula and calculation
Beta · 5-year monthly1.78Saved five-year monthly beta; measures historical sensitivity to the benchmark.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingBeta
2026-08-311.78

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
TuHURA Biosciences, Inc./NV (HURA)United States$0.134B-4.88
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31
Curanex Pharmaceuticals Inc (CURX)United States$0.138B
MEDICINOVA INC (MNOV)United States$0.130B-6.04
Atrium Therapeutics, Inc. (RNA)United States$0.140B
Korro Bio, Inc. (KRRO)United States$0.141B-1.81
IMMUNIC, INC. (IMUX)United States$0.127B-1.88
SPRUCE BIOSCIENCES, INC. (SPRB)United States$0.142B-2.89
INOVIO PHARMACEUTICALS, INC. (INO)United States$0.125B-1.35
Corbus Pharmaceuticals Holdings, Inc. (CRBP)United States$0.144B-1.72